Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-1735PMID 16397244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking

  2005influential reference
• PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

  2005influential reference
• Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

  2004cited by this paper
• Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

  2004cited by this paper
• Formation of tissue factor–factor VIIa–factor Xa complex promotes cellular signaling and migration of human breast cancer cells

  2004cited by this paper
• Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2*

  2004cited by this paper
• Persistent Signaling by Dysregulated Thrombin Receptor Trafficking Promotes Breast Carcinoma Cell Invasion

  2004influential reference
• A multigenic program mediating breast cancer metastasis to bone.

  2003cited by this paper
• Specificity of coagulation factor signaling

  2003cited by this paper
• Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness.

  2003cited by this paper
• Genetic Evidence That Protease-activated Receptors Mediate Factor Xa Signaling in Endothelial Cells*

  2002cited by this paper
• Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway

  2002cited by this paper
• β-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation*

  2002cited by this paper
• Protease-Activated Receptor-2 Stimulates Angiogenesis and Accelerates Hemodynamic Recovery in a Mouse Model of Hindlimb Ischemia

  2002cited by this paper
• Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues.

  2001cited by this paper
• Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.

  2001cited by this paper
• Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1.

  2001cited by this paper
• Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.

  2000cited by this paper
• β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2

  2000cited by this paper
• Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

  2000cited by this paper
• Role of thrombin receptor in breast cancer invasiveness

  1999cited by this paper
• Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.

  1999cited by this paper
• Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.

  1998cited by this paper
• Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis.

  1998cited by this paper
• Thrombin receptor overexpression in malignant and physiological invasion processes

  1998cited by this paper
• Defective platelet activation in G alpha(q)-deficient mice.

  1997cited by this paper
• Defective platelet activation in Gαq-deficient mice

  1997cited by this paper
• Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2*

  1996cited by this paper
• Expression cloning of oncogenes by retroviral transfer of cDNA libraries

  1995cited by this paper
• Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo.

  1992cited by this paper
• Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.

  1992cited by this paper
• Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.

  1992cited by this paper
• Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formation a

  1992influential reference
• A rapid in vitro assay for quantitating the invasive potential of tumor cells.

  1987cited by this paper
• Tumor cell generation of thrombin via functional prothrombinase assembly.

  1985cited by this paper

• Decoding ECM remodeling: proteases as gatekeepers of Lysyl oxidase family-mediated crosslinking.

  2026cites this paper
• Patient-Derived Procoagulant Breast Fibroblasts Expressing Tissue Factor Promote Breast Cancer Cell Migration.

  2026cites this paper
• Significance of FXa and its receptor PAR2 for the growth of colon cancer cells in vitro and in vivo

  2025cites this paper
• The role of tissue factor in the tumor microenvironment and targeted therapy.

  2025cites this paper
• Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes

  2025cites this paper
• Non-classical neutrophil extracellular traps induced by PAR2-signaling proteases

  2025cites this paper
• Targeting the PRSS3-PAR2-ERK1/2 Axis Inhibits Malignancy and Regulates Chemosensitivity and Resistance through Ferroptosis in Breast Cancer.

  2025cites this paper
• Effects of DOACs on Mouse Melanoma Metastasis and the Inhibitory Mechanism of Edoxaban, a Factor Xa-Specific DOAC

  2025cites this paper
• New Target(s) for RNF43 Regulation: Implications for Therapeutic Strategies

  2024cites this paper
• Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma

  2024cites this paper
• A review concerning the breast cancer-related tumour microenvironment.

  2024cites this paper
• Par2-mediated responses in inflammation and regeneration: choosing between repair and damage

  2024cites this paper
• Endothelial PAR2 activation evokes resistance artery relaxation

  2023cites this paper
• Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase

  2023cites this paper
• Endothelial APC/PAR1 distinctly regulates cytokine-induced pro-inflammatory VCAM-1 expression

  2023cites this paper
• Proteinase-activated Receptor 2: Springboard of Tumors

  2023cites this paper
• Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells

  2023cites this paper
• An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses

  2023cites this paper
• Lysyl oxidase-like 2 processing by factor Xa modulates its activity and substrate preference

  2023cites this paper
• Tissue factor as a new target for tumor therapy—killing two birds with one stone: a narrative review

  2022cites this paper
• Expression of Proteinase-activated Receptor 2 (PAR2) as a Correlate of Concern in Triple-negative Breast Cancer (TNBC)

  2022cites this paper
• Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)

  2022cites this paper
• Protease-Activated Receptors in Health and Disease.

  2022cites this paper
• Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma

  2022cites this paper
• Edoxaban, a Factor Xa-Specific Direct Oral Anticoagulant, Significantly Suppresses Tumor Growth in Colorectal Cancer Colon26-Inoculated BALB/c Mice

  2022cites this paper
• Matriptase activation of Gq drives epithelial disruption and inflammation via RSK and DUOX

  2021cites this paper
• Targeting Innate Immunity in Cancer Therapy

  2021cites this paper
• Protein profile of MCF-7 breast cancer cell line treated with lectin delivered by CaCO3NPs revealed changes in molecular chaperones, cytoskeleton, and membrane-associated proteins.

  2021cites this paper
• Protease Activated Receptor 1 and Its Ligands as Main Regulators of the Regeneration of Peripheral Nerves

  2021cites this paper
• Molecular Mechanisms of Canine Osteosarcoma Metastasis

  2021cites this paper
• GPCR Partners as Cancer Driver Genes: Association with PH-Signal Proteins in a Distinctive Signaling Network

  2021cites this paper
• Peptides and Peptidomimetics as Foundations for Drug Discovery

  2021cites this paper
• Molecular mechanisms regulating Proteinase‐Activated Receptors (PARs)

  2021cites this paper
• Matriptase generates a tissue damage re- sponse via promoting Gq signalling, leading to RSK and DUOX activation Running Title: Matriptase activation of a tissue damage response

  2021cites this paper
• The Role and Expression of Angiogenesis-Related miRNAs in Gastric Cancer

  2021cites this paper
• The PAR2 inhibitor I-287 selectively targets Gαq and Gα12/13 signaling and has anti-inflammatory effects

  2020cites this paper
• The PAR2 inhibitor I-287 selectively targets Gαq and Gα12/13 signaling and has anti-inflammatory effects

  2020cites this paper
• Discovery of Novel Nonpeptidic PAR2 Ligands.

  2020cites this paper
• Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial

  2020cites this paper
• Gastric carcinogenesis: a comprehensive review of the angiogenic pathways

  2020cites this paper
• The role of tissue factor in metastasising, neoangiogenesis and hemostasis in cancer

  2019cites this paper
• Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases

  2019cites this paper
• A study of clinicopathological characteristics, symptoms and patients experiences related to outcomes in people with cancer and I-PE

  2019cites this paper
• Gerinnungsproteasen als Therapie der Sepsis

  2019cites this paper
• Proteinase-activated receptor 2 deficiency is a protective factor against cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury

  2019cites this paper
• Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition

  2019cites this paper
• Reviewing the role of P2Y receptors in specific gastrointestinal cancers

  2019cites this paper
• The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice

  2019cites this paper
• THE PROGNOSTIC ROLE OF MAST CELLS ACCORDING WITH THE HISTOLOGICAL GROWTH PATTERN IN LIVER METASTASIS OF TUMORS WITH DIGESTIVE ORIGINS

  2019cites this paper
• Tumor progression-dependent angiogenesis in gastric cancer and its potential application

  2019cites this paper
• Cancer and Blood Coagulation

  2019cites this paper
• Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer

  2018cites this paper
• Protease‐activated receptor 2 promotes actomyosin dependent transforming microvesicles generation from human breast cancer

  2018cites this paper
• Inhibition of Intestinal Epithelial Wound Healing through Protease-Activated Receptor-2 Activation in Caco2 Cells

  2018cites this paper
• Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.

  2018cites this paper
• GPCRs: Emerging anti-cancer drug targets.

  2018cites this paper
• Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer

  2018cites this paper
• Proteomics Comparison of Breast Cancer with Adjacent Normal Tissues in Women with Breast Cancer

  2018cites this paper
• Tumor-Associated Macrophages and Mast Cells Positive to Tryptase Are Correlated with Angiogenesis in Surgically-Treated Gastric Cancer Patients

  2018cites this paper
• Drug repositioning as an effective therapy for protease‐activated receptor 2 inhibition

  2018cites this paper
• Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer

  2018cites this paper
• Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology

  2017cites this paper
• Factor Xa Signaling Contributes to the Pathogenesis of Inflammatory Diseases

  2017cites this paper
• Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression

  2017cites this paper
• Biodegradable Enzymatically Activated Nanoprobes for Dual Imaging and Therapy of Breast Cancer

  2017cites this paper
• Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer

  2017influential citation
• Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents.

  2017cites this paper
• In vitro effects of Apixaban on 5 different cancer cell lines

  2017cites this paper
• The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients

  2017cites this paper
• Transforming Growth Factor-β1/Activin Receptor-like Kinase 5-Mediated Cell Migration is Dependent on the Protein Proteinase-Activated Receptor 2 but not on Proteinase-Activated Receptor 2-Stimulated Gq-Calcium Signaling

  2017cites this paper
• Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance

  2017cites this paper
• Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer

  2017cites this paper
• Platelet-targeted pharmacologic treatments as anti-cancer therapy

  2017cites this paper
• Serine Proteases and Their Inhibitors in Human Health and Disease

  2017cites this paper
• Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery

  2016cites this paper
• Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5

  2016cites this paper
• Longitudinal association of hemostatic factors with risk for cancers of the breast, colorectum, and lung among postmenopausal women

  2016influential citation
• Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery

  2016cites this paper
• Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells – evidence for a role in hepatocellular carcinoma growth in vivo

  2016cites this paper
• Biased signaling: potential agonist and antagonist of PAR2

  2016cites this paper
• Proteinases, Their Extracellular Targets, and Inflammatory Signaling

  2016cites this paper
• β‐Arrestin1 regulates the morphology and dynamics of microglia in zebrafish in vivo

  2016cites this paper
• Tissue Factor promotes breast cancer stem cell activity in vitro

  2016cites this paper
• High infiltration of mast cells positive to tryptase predicts worse outcome following resection of colorectal liver metastases

  2015cites this paper
• The Role of Coagulation Factor Signaling in Angiogenesis and Vascular Remodeling

  2015cites this paper
• Infiltrating Mast Cells Correlate with Angiogenesis in Bone Metastases from Gastric Cancer Patients

  2015cites this paper
• Protease-activated receptor 2 modulates proliferation and invasion of oral squamous cell carcinoma cells.

  2015cites this paper
• Suppressing the TF-fVII pathway at the gene expression level: A strategy to inhibit aberrant signaling cascades associated with cancer cells

  2015cites this paper
• Protease-activated receptor 2 modulates proliferation and invasion of oral squamous cell

  2015cites this paper
• Tissue Factor: Old and New Links with Cancer Biology

  2015cites this paper
• Sodium channel Nax is a regulator in epithelial sodium homeostasis

  2015cites this paper
• Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status

  2015cites this paper
• Targeting mast cells in gastric cancer with special reference to bone metastases.

  2015cites this paper
• Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis

  2015influential citation
• Tissue Factor and Breast Cancer

  2015cites this paper
• Protease activated receptor-2 (PAR2): possible target of phytochemicals

  2015cites this paper
• Role of the protein C receptor in cancer progression.

  2014cites this paper
• Biased Signaling of Protease-Activated Receptors

  2014cites this paper
• Structure and putative signaling mechanism of Protease activated receptor 2 (PAR2) - a promising target for breast cancer.

  2014cites this paper
• DOCTEUR DE L'UNIVERSITE DE REIMS CHAMPAGNE - ARDENNE Discipline : Biologie Cellulaire et Moléculaire

  2014cites this paper